Merrimack Pharmaceuticals, Inc.
One Kendall Square
Building 700, 2nd Fl
Cambridge, MA 02139

Phone: 617-441-1000
Fax: 617-491-1386

Email:info@merrimackpharma.com

Merrimack Pharmaceuticals is an integrated, biopharmaceutical company committed to the innovation of life-enhancing medicines for the treatment of autoimmune disease and cancer. Merrimack is privately held and located in Cambridge, Massachusetts.

 

LATEST NEWS

June 10 , 2008 - Press Release
Merrimack Pharmaceuticals Raises $60 Million in Private Financing

April 24, 2008 - Press Release
In vivo Safety and Efficacy data on MM-121, Merrimack's Most Advanced Oncology Product, presented during the Annual Meeting of the American Association for Cancer Research.

March 14, 2008 - Press Release
Merrimack Pharmaceuticals Completes Enrollment in a Phase 2 Study of MM-093 in Patients with Rheumatoid Arthritis.

 
       
 
Site Design by Digizyme
 
About Pipeline Research & Development News & Events Careers Contact Merrimack Pharmaceuticals